摘要
目的:探讨急性冠脉综合征(ACS)患者血清肝细胞生长因子(HGF)水平变化的临床意义。方法:160例住院患者分为急性心肌梗死(AMI)、不稳定型心绞痛(UA)、稳定型心绞痛(SA)及对照组(C),检测各组血清HGF水平。随访ACS患者5年内不良心血管事件的发生情况。结果:ACS患者早期血清HGF水平明显升高,发生不良心血管事件者血清HGF水平与未发生者有显著差异。结论:血清HGF浓度对ACS的早期诊断、危险分层及预后均有重要意义。
Objective: To patients with acute coronary myocardial infarction group ( 20) and control group (C, investigate the clinical significance of serum hepatocyte growth factor (HGF) level in syndrome (ACS). Methods: A total of 160 patients were divided into acute AMI, n = 60), unstable angina group (UA, n = 60), stable angina group (SA, n = n = 20). The serum HGF concentration was measured for all patients. The major adverse cardiovascular event (MACE) was observed in 5 years for ACS patients. Results: Serum HGF level was significantly higher in the patients with ACS. There was a significant difference in serum HGF levels between ACS patients with and without MACE. Conclusion: The HGF level might play an important role in early diagnosis and assessing the status and prognosis of ACS.
出处
《西北国防医学杂志》
CAS
2012年第4期435-437,共3页
Medical Journal of National Defending Forces in Northwest China
关键词
急性冠脉综合征
肝细胞生长因子
诊断
预后
Acute coronary syndrome
Hepatocyte growth factor
Diagnosis
Prognosis